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Abstract 
Background: We examined whether face-emotion labeling deficits are illness-specific or an 
epiphenomenon of generalized impairment in pediatric psychiatric disorders involving mood and 
behavioral dysregulation. 
Method: Two hundred fifty-two youths (7-18 years old) completed child and adult facial 
expression recognition subtests from the Diagnostic Analysis of Nonverbal Accuracy (DANVA) 
instrument. Forty-two participants had bipolar disorder (BD), 39 had severe mood dysregulation 
(SMD; i.e., chronic irritability, hyperarousal without manic episodes), 44 had anxiety and/or 
major depressive disorders (ANX/MDD), 35 had attention-deficit/hyperactivity and/or conduct 
disorder (ADHD/CD), and 92 were controls. Dependent measures were number of errors 
labeling happy, angry, sad, or fearful emotions. 
Results: BD patients made more errors than ANX/MDD, ADHD/CD, or controls when labeling 
all emotional expressions, whether those expressions were on the faces of children or adults. 
SMD also showed emotion-labeling deficits, in particular as compared to ANX/MDD patients 
and controls. 
Conclusions: Face-emotion labeling deficits differentiate BD and SMD patients from those with 
ANX/MDD or ADHD/CD and controls. The extent to which such deficits cause vs. result from 
emotional dysregulation requires further study. 
Keywords: Emotion recognition, Bipolar disorder, Emotion regulation, Paediatrics 
Abbreviations: SMD, DANVA 
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The study of face-emotion processing in children with psychopathology may elucidate 
associations between emotion labeling deficits and social impairment (Nowicki & Mitchell, 
1998). Also, the neural mechanisms mediating face-emotion processing are relatively well-
defined (Sprengelmeyer, Rausch, Eysel, & Przuntek, 1998); thus, identification of emotion 
labeling deficits in children with psychopathology may implicate specific neural circuits in the 
pathophysiology of their illness. 
Most research on facial affect labeling and psychopathology has focused on adults (Gur 
et al., 1992; Lembke & Ketter, 2002; Philippot & Douilliez, 2005). However, because youth with 
psychopathology often have social impairment (Geller et al., 2000; Ginsburg, La Greca, & 
Silverman, 1998; Maedgen & Carlson, 2000; Rudolph, Hammen, & Burge, 1994), studies have 
begun to examine face-emotion processing in such youth. Much work on face processing in 
youth has focused on pervasive developmental disorders (PDD), since deficits in social cognition 
and communication are cardinal features of these conditions (Dawson, Webb, Wijsman et al., 
2005). However, significant social impairment is also present in youth with disorders 
characterized by emotional and/or behavioral dysregulation, including anxiety (ANX), major 
depression (MDD), attention deficit/hyperactivity (ADHD), conduct disorder (CD), and bipolar 
disorder (BD). Given that information-processing biases differ across these diagnostic groups 
(Dalgleish et al., 2003), these disorders may also be characterized by different face-emotion 
processing profiles. 
Indeed, existing studies provide suggestive evidence about differences in emotion-
processing across pediatric diagnostic groups. Some studies link pediatric anxiety and impaired 
emotion recognition (Easter et al., 2005; Melfsen & Florin, 2002; Simonian, Beidel, Turner, 
Berkes, & Long, 2001); others do not (Manassis & Young, 2000; McClure, Pope, Hoberman, 
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Pine, & Leibenluft, 2003). One study found that youth with MDD/dysthymia had difficulty 
recognizing negative emotions (Lenti, Giacobbe, & Pegna, 2000). Data indicate BD youths have 
facial expression labeling deficits (McClure et al., 2003; McClure et al., 2005; Rich et al., 2006), 
consistent with their social problems (Geller et al., 2000; Lewinsohn, Seeley, & Klein, 2003; 
Towbin, Pradella, Gorrindo, Pine, & Leibenluft, 2005). Similarly, ADHD youths have social 
dysfunction (Maedgen & Carlson, 2000); while three studies identified emotion recognition 
deficits in ADHD youth (Corbett & Glidden, 2000; Pelc, Kornreich, Foisy, & Dan, 2006; 
Shapiro, Hughes, August, & Bloomquist, 1993), another suggested that these deficits reflect 
inattention rather than misinterpretation of emotions (Cadesky, Mota, & Schachar, 2000). 
Together, these studies suggest BD youths have face-emotion labeling deficits, ADHD youths 
may have deficits linked to inattention or inaccurate encoding, and the performance of anxious 
and depressed youths is unclear.  
The use of different emotion recognition paradigms, however, makes it difficult to 
compare outcomes across studies. Additionally, most studies compare healthy youth to one, or at 
most two, psychiatrically-ill groups. Thus, it is unclear whether face-emotion labeling deficits in 
pediatric psychiatric disorders are illness-specific or epiphenomena of generalized impairment. 
Specific behavioral deficits may implicate illness-specific neural deficits, facilitating research on 
the pathophysiology of psychiatric disorders.  
We examined face-emotion processing across a range of pediatric psychiatric conditions 
using a widely-used, standardized emotion recognition paradigm (Cadesky et al., 2000; Manassis 
& Young, 2000; Nowicki & Duke, 1994; Plesa-Skwerer, Faja, Schofield, Verbalis, & Tager-
Flusberg, 2006). We compared face-emotion labeling among four patient groups: youth with 
ANX and/or MDD (ANX/MDD), ADHD and/or CD (ADHD/CD), BD, and patients classified as 
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having severe mood dysregulation (SMD) (Leibenluft, Charney, Towbin, Bhangoo, & Pine, 
2003). Children with SMD have severe, chronic irritability and hyperarousal. The SMD 
syndrome was defined to capture children whose nosologic status vis-a-vis BD is unclear; 
specifically, it is unknown whether SMD is a pre-pubertal presentation of BD (Leibenluft et al., 
2003; Nottelmann et al., 2001) and/or an early manifestation of depression (Brotman et al., 2006; 
Leibenluft, Cohen, Gorrindo, Brook, & Pine, 2006). The SMD population is important to study 
because the syndrome is common (Brotman et al., 2006), impairing, and associated with social 
dysfunction (Towbin et al., 2005). 
Based on data indicating that pediatric BD patients mislabel facial emotion (McClure et 
al., 2003; McClure et al., 2005; Rich et al., 2006), we hypothesized that they would perform 
more poorly on face-emotion labeling than all other groups, except for SMD patients. Because 
SMD shares some clinical features with pediatric BD, and thus may be a phenotype of pediatric 
BD (Leibenluft et al., 2003), we hypothesized that face-emotion labeling deficits in SMD would 
be similar to those in BD and differ from those in other patients and controls. Finally, we also 
examined whether the age of stimulus face or emotion expressed in the face moderated group 
differences in errors. 
Method 
Participants 
The National Institute of Mental Health (NIMH) and National Institute of Drug Abuse 
(NIDA) Institutional Review Boards approved the study and all participants/parents provided 
written informed assent/consent. Participants were 7-18 years old. BD (n=42), SMD (n=39), and 
ANX/MDD (n=44) patients were enrolled in studies at the NIMH. DSM-IV-based diagnoses 
were generated from the Schedule for Affective Disorders and Schizophrenia for School-Age 
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Children-Present and Lifetime version (K-SADS-PL) (Kaufman et al., 1997). The K-SADS-PL 
was conducted with children and their parents separately by psychiatrists/psychologists with high 
inter-rater reliability (kappa H0.75, based on blind review of taped evaluations). A K-SADS-PL 
module determined SMD diagnosis. 
BD patients met criteria for the “narrow phenotype” of pediatric BD, including history of 
at least one (hypo)manic episode meeting DSM-IV-TR duration criteria (i.e., H4 days for 
hypomania, H7 days for mania), elevated/expansive mood, and H3 other “B” symptoms (Geller et 
al., 2002; Leibenluft et al., 2003). SMD patients had abnormal baseline mood (anger or sadness, 
at least half the day most days and noticeable by others), hyper-reactivity to negative emotional 
stimuli (e.g., explosive, developmentally inappropriate outbursts at least 3x/week), and 
hyperarousal (H3 of: insomnia, intrusiveness, pressured speech, flight of ideas/racing thoughts, 
distractibility, psychomotor agitation) (Leibenluft et al., 2003). SMD symptoms must begin 
before age 12, occur for H1 year without remission exceeding two months, and cause severe 
impairment (e.g., hospitalization, repeated grade) in H1 setting (e.g., home, school, peers) and 
mild impairment (e.g., poor academic performance, disciplinary problems) in another. Those 
with euphoric mood or distinct (hypo)manic episodes lasting H1 day were excluded from the 
SMD group.  
ANX patients had current generalized anxiety, social phobia, and/or separation anxiety. 
MDD patients met criteria for current major depression. Other inclusion criteria for ANX/MDD 
patients were 1) Pediatric Anxiety Rating Scale (PARS) (RUPP, (2002)) scores H10 and/or 
Children’s Depression Rating Scale (CDRS) (Poznanski et al., 1984) scores H39; 2) Children’s 
Global Assessment Scale (CGAS) (Shaffer et al., 1983) scores <60; and 3) persistent anxiety 
and/or depression (consistently elevated PARS and/or CDRS) during supportive psychotherapy 
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(McClure et al., in press; Monk et al., 2006; RUPP, 2001). Among ANX/MDD patients, 26 had 
ANX, 14 had ANX+MDD, and four had MDD (see Data Analysis for rationale to combine 
patients). 
ADHD/CD participants (n=35) were enrolled in a longitudinal study of risk factors for 
substance abuse at the NIDA (Ernst et al., 2006). Participants and their parents were 
administered the Diagnostic Interview for Children and Adolescents (DICA-R), a structured 
psychiatric interview (Reich, 2000), by trained master’s- and bachelor’s-level research assistants. 
Two child psychiatrists used the DICA-R and additional information obtained from adolescents, 
parents, and teachers to determine DSM-IV-based diagnoses. ADHD/CD patients included 18 
with ADHD, 10 with ADHD+CD, and 7 with CD (see Data Analysis). 
Controls were 92 adolescents identified as psychiatrically healthy based on the K-SADS-
PL/DICA-R. Data comparing BD patients (n=39) to subsets of control (n=24) and ANX/MDD 
(n=10) participants on face-emotion labeling have been published (McClure et al., 2003; 
McClure et al., 2005). 
Exclusion criteria for all groups included: IQ <70; unstable/chronic medical illness; 
history of PDD, head trauma, or substance use within past two months (any substance use history 
for ADHD/CD). Because the K-SADS and DICA-R do not assess for the presence of PDD, 
exclusion for PDD was based on history of a PDD diagnosis or clinical observation of severely 
impaired interpersonal functioning during the diagnostic interview; judgment from experienced 
clinicians reliably differentiates children with and without PDD (Lord et al., 2006; Mahoney et 
al., 1998). Children with ANX or MDD were excluded from the ADHD/CD group. Additional 
exclusion criteria for ANX/MDD and ADHD/CD patients included: current Tourette’s syndrome 
or obsessive compulsive disorder; posttraumatic stress disorder; exposure to extreme trauma; 
Face-emotion labeling deficits 
 
7
suicidal ideation; history of mania or psychosis; use of psychotropic medications (except 
stimulants for ADHD/CD). 
Measures 
The Diagnostic Analysis of Nonverbal Accuracy (DANVA) (Nowicki & Duke, 1994) 
Child and Adult Facial Expressions subtests were used to assess face-emotion labeling. Each 
computer-administered subtest includes 24 photographs of child or adult models (12 female, 12 
male per subtest) displaying equal numbers of high- and low-intensity expressions of happiness, 
sadness, anger, and fear. Faces appear for 2 seconds. In a forced-choice format, participants 
indicate by button-press which emotion a face expresses. Both subtests have been standardized 
and have acceptable internal consistency and reliability (Nowicki & Carton, 1993; Nowicki & 
Duke, 1989; Nowicki & Duke, 1994). The dependent variable was total errors, i.e., misidentified 
emotions, created separately for each subtest and each emotion. High- and low-intensity 
expressions were combined to increase power. 
IQ was assessed with the Wechsler Abbreviated Scale of Intelligence (WASI) (Wechsler, 
1999) for all but ADHD/CD participants, who completed the abbreviated Wechsler Intelligence 
Scale for Children (WISC-III) (Wechsler, 1991). 
Functional impairment of BD, SMD, and ANX/MDD patients was measured with the 
CGAS. BD and SMD mood state was assessed at testing using the Young Mania Rating Scale 
(YMRS) (Young, Biggs, Ziegler, & Meyer, 1978) and CDRS. However, since, by definition, 
SMD children have not had a DSM-IV hypomanic or manic episode, elevated YMRS scores in 
this population indicate hyperarousal, not mania per se. CDRS and YMRS ratings were used to 
assign mood states as follows: euthymic: YMRS <12, CDRS <40; depressed: YMRS <12, CDRS 
>40; (hypo)manic [BD only]: YMRS >12, CDRS <40; mixed [BD only]: YMRS >12, CDRS 
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>40. The Screen for Child Anxiety Related Disorders (SCARED) (Birmaher et al., 1997) 
assessed severity of anxiety symptoms (scores H25 indicate disorder) in ANX/MDD patients. 
Conners’ Parent Rating Scale (Conners, 1989) assessed severity of hyperactivity in ADHD/CD 
patients at testing. 
Data Analysis 
ANX, MDD, and ANX+MDD participants, on the one hand, and ADHD, CD, and 
ADHD+CD participants, on the other, were combined to maximize statistical power for two 
reasons. First, since comorbidity rates among these disorder clusters are high (Axelson & 
Birmaher, 2001; Biederman, Newcorn, & Sprich, 1991), it is not feasible to compare individual 
disorders. Second, preliminary analyses comparing errors among the narrowly-defined groups 
indicated similar mean scores among the ANX, MDD, and ANX+MDD groups (p-values: 0.35-
0.93), and among ADHD, CD, and ADHD+CD (p-values: 0.23-0.95). This overlap in 
performance is supported by other research on face-emotion labeling comparing ANX and 
ANX+MDD (Monk et al., 2006), and ADHD and CD (Cadesky et al., 2000). 
Analyses of variance assessed group differences in age, IQ, and CGAS scores. 
Significant differences were interpreted with Tukey’s pairwise tests. Chi-squares assessed group 
differences in sex and ethnicity (white or non-white, given small cell sizes for non-white 
ethnicities). Because of age, IQ, sex, and ethnicity group differences (see Results), these 
variables served as covariates. 
A 5 (group) x 2 (face-age) x 4 (emotion) repeated measures analysis of covariance 
(ANCOVA) of errors tested main effects of group, face-age, and emotion, and group by face-age 
and group by emotion interactions. Wilks’ Lambda was used to test the significance of within-
group factors and interactions. Significant F statistics were interpreted with Bonferroni-corrected 
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post-hoc tests. Analyses used two-tailed significance tests (S=0.05). Partial eta-squared (Tp2) is 
reported for effect size. 
Results 
Demographic and Clinical Characteristics (Tables 1 and 2) 
Groups differed in age, F(4,247)=12.63, p<0.001; controls and ADHD/CD were older 
than ANX/MDD, SMD, and BD patients (p-values <0.02). IQ differed among groups, 
F(4,247)=2.36, p=0.05. Controls had higher IQ scores than ADHD/CD patients (mean 
difference=8.01, p=0.06); all other groups had comparable IQs. Sex distribution across groups 
tended to be different, U²(4,N=252)=8.53, p=0.07; more males were in the ADHD/CD (71%) and 
SMD (72%) groups than in the other groups. The proportion of white vs. non-white participants 
was greater among BD and SMD than other groups, U²(4,N=252)=23.87, p<0.001. Thus, age, IQ, 
sex, and ethnicity were covariates in all statistical models. 
Regarding mood state at testing, 59.5% of BD (n=25) and 47.6% of SMD (n=20) patients 
were euthymic. Of 14 non-euthymic BD patients, 11 were hypomanic and three were in a mixed 
mood state. Four SMD patients were depressed. Among ANX/MDD patients, 56.8% (n=25) had 
elevated anxiety based on the SCARED (M=27.80±13.53). Among ADHD/CD patients, mean 
Conners’ hyperactivity score was 17.14±4.16. 
BD, SMD, and ANX/MDD patients’ CGAS scores indicated moderate impairment and 
did not differ significantly (BD: M=50.27±11.28; SMD: M=48.84±7.67; ANX/MDD: 
M=49.05±7.76). 
Thirty-three BD, 17 SMD, and 17 ADHD/CD patients were receiving psychotropic 
medication. ANX/MDD patients were medication-free. 
Emotion Labeling Errors 
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A significant main effect indicated that the groups differed in face-emotion labeling 
errors, F(4,243)=8.51, p<0.001, Tp2=0.12 (Figure 1). Post-hoc comparisons indicated that BD 
youth made more errors than all other groups (each p-value <0.001) except SMD. SMD youth 
committed significantly more errors than ANX/MDD youth (p=0.03). Comparison of SMDs and 
controls was not significant after Bonferroni-correction; however, because we had an a priori 
hypothesis concerning this contrast, Bonferroni-correction is conservative. When compared to 
controls only, SMDs made significantly more errors, F(1,125)=6.84, p=.01, Tp2=0.05.  
A significant emotion effect was also found, F(3,241)=3.46, p=0.02, Tp2=0.04. Post-hoc 
tests showed that all subjects made more errors on angry than fearful, sad, and happy 
expressions; on fearful than sad and happy expressions; and on sad than happy expressions. 
Interactions between group and face-age or emotion were not significant, indicating that the 
impact of face-age or emotion on errors did not differ across groups. Increasing age and higher 
IQ were associated with fewer errors, Age: F(1,243)=12.25, p=0.001, Tp2=0.05, and IQ: 
F(1,243)=13.87, p<0.001, Tp2=0.05. 
Post-hoc Analyses 
Post-hoc analyses assessed effects of mood state and medications on face-emotion 
labeling in BD and SMD patients. Euthymic BDs (n=25) and controls (n=92) were compared to 
examine whether labeling deficits in BDs are trait-related. Euthymic BDs made more errors than 
controls, F(1,111)=19.80, p<0.001. Additionally, euthymic BDs (n=25) and symptomatic BDs 
(n=14) did not differ in performance, F(1,33)=0.65, p=0.43. SMDs were not divided by mood 
state because an insufficient number were depressed. 
 Unmedicated BDs (n=9) and unmedicated SMDs (n=22) were each compared to controls 
and to medicated patients. Unmedicated BDs made more errors (M=1.80±0.17) than controls 
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(M=0.83±0.05), F(1,95)=30.65, p<0.001, and unmedicated BDs (M=1.84±0.18) made slightly 
more errors than medicated BDs (M=1.22±0.09), F(1,36)=9.23, p=0.004. Errors were 
significantly more common in unmedicated SMDs (M=1.18±0.10) than in controls 
(M=0.85±0.05), F(1,108)=8.36, p=0.005, but unmedicated and medicated SMDs did not differ in 
errors, F(1,33)=0.95, p=0.34. 
Discussion and Conclusion 
We tested the specificity of facial expression labeling deficits in a large sample of youths 
with disorders characterized by emotional and/or behavioral dysregulation. Two main findings 
emerged. First, as hypothesized, when labeling emotional expressions in faces, BD patients made 
more errors than did youths with anxiety and/or MDD, ADHD and/or CD, or controls. Second, 
SMDs showed face-emotion labeling deficits when judging faces, particularly as compared to 
ANX/MDD patients and controls. 
Past work shows that youths with “narrow phenotype” BD have a deficit in facial affect 
labeling (McClure et al., 2003; McClure et al., 2005; Rich et al., 2006). The present study 
extends prior work by demonstrating that this deficit emerges relative to youths with other 
psychiatric disorders and similar levels of impairment. Additionally, anxiety, ADHD, and CD are 
common comorbidities in BD patients (Biederman, Faraone, Chu, & Wozniak, 1999; Carlson, 
1998; Dickstein et al., 2005); the current data, indicating that ANX/MDD and ADHD/CD 
resemble controls on face-emotion labeling ability, suggest that labeling deficits in pediatric BD 
are probably associated with BD itself, rather than the associated comorbidities.  
SMDs were the only group other than BDs to exhibit face-emotion labeling deficits, 
although SMD deficits were not as marked as BD deficits. In analyses involving all groups, 
SMDs made more errors than ANX/MDD patients. When compared directly to controls only, 
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SMDs performed significantly worse, providing further support for face-emotion labeling 
deficits in SMD. Researchers debate whether SMD is a developmental presentation of BD, since 
emotional lability, irritability, and hyperarousal are prominent in both syndromes (Leibenluft et 
al., 2003). By measuring face-emotion labeling, our results add a new dimension to the 
heretofore clinically-focused debate about the classification of these two pediatric BD 
phenotypes. Our data suggest that the pathophysiology of SMD and BD may overlap, in that 
both are associated with face-emotion labeling deficits absent in other psychiatrically-ill groups. 
ADHD/CD and ANX/MDD patients performed similarly to controls on face-emotion 
labeling. Our results replicate those of related studies in ADHD. For example, data indicate that 
children with ADHD and CD are as accurate as controls on the DANVA (Cadesky et al., 2000), 
and that ADHD children age 8 and older process facial affective cues as well as controls 
(Shapiro et al., 1993). In contrast, two studies found 7-12 year olds with ADHD less accurate at 
labeling emotions than controls (Corbett & Glidden, 2000; Pelc et al., 2006). In our study, none 
of the ADHD/CD patients was younger than 12 years. Thus, preadolescent ADHD children 
could have greater difficulty labeling facial emotions than do older ADHD children. 
Data regarding face-emotion labeling in ANX/MDD are inconsistent. Three studies show 
that children with anxiety misidentify adult emotions (Easter et al., 2005; Melfsen & Florin, 
2002; Simonian et al., 2001), and one study found a similar pattern in depressed children (Lenti 
et al., 2000). However, two studies using the DANVA (one of which included 10 ANX patients 
from the current sample) found no differences between anxious and control youths (Manassis & 
Young, 2000; McClure et al., 2003). Notably, the present study includes the largest ANX/MDD 
sample yet reported. As such, these findings suggest the absence of strong associations between 
ANX/MDD and face-emotion labeling deficits. However, the DANVA assesses face-emotion 
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labeling, whereas other studies of anxious youth use tasks designed to assess attentional biases 
while viewing facial expressions (e.g., dot probe tasks) (Bradley, Mogg, White, Groom, & de 
Bono, 1999; Mogg, Philippot, & Bradley, 2004). Different face-emotion processing tasks may 
yield different results across patient populations. Finally, different results across studies of face-
emotion labeling in anxiety may reflect the fact that our study included youth with a range of 
anxiety disorders (57% had social phobia, 46% had generalized anxiety, 23% had separation 
anxiety, and 18% had specific/simple phobia), whereas other studies only included youth with a 
specific anxiety disorder such as social phobia (Melfsen & Florin, 2002; Simonian et al., 2001).  
In the current study, in all of the groups, face labeling ability did not differ based on the 
age of the face or the specific emotion displayed. Thus, BD and SMD patients have deficits 
labeling emotions on both adult and child faces and across emotions. In an initial study, we 
found that BD patients made more errors on child than adult faces (McClure et al., 2003). 
However, in a later study (McClure et al., 2005) and here, we included a much larger sample of 
BD, ANX, and control subjects, and found that BD subjects performed poorly when labeling 
emotions on children’s and adults’ faces. Across all groups, we found that emotion-specific 
errors increased in the following order: happiness, sadness, fear, and anger. This is consistent 
with work documenting greater accuracy for happiness than for negative emotions (Gross & 
Ballif, 1991; Mufson & Nowicki, 1991). 
We excluded children with PDD. Like BD and SMD youths, children with PDD have 
impaired social behavior, including difficulty responding to others’ emotional cues (Dawson, 
Webb, & McPartland, 2005). Indeed, both BD and SMD youths frequently display some PDD 
symptoms (Towbin et al., 2005; Wozniak et al., 1997). Thus, further research is needed to 
understand relationships among BD, SMD, PDD, and face-emotion processing. 
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Identification of emotion labeling deficits can guide research on the pathophysiology of 
SMD and BD. Indeed, research indicates an association between face-emotion labeling deficits 
and amygdala hyperactivity in youth with BD youth (Rich et al., 2006). Comparative functional 
magnetic resonance imaging (fMRI) studies of BD and SMD patients will help elucidate whether 
similar brain/behavior relationships mediate face-emotion processing deficits in these patient 
groups. 
This study should be considered in light of five limitations. First, many BD and SMD 
patients were taking psychotropic medications at testing. Because medication discontinuation is 
ethically constrained, it is difficult to recruit pediatric patients who are severely impaired but 
unmedicated. However, post-hoc analyses demonstrated that even unmedicated BD and SMD 
patients performed significantly worse than controls. Unmedicated and medicated SMD patients 
did not perform differently; although the performance of unmedicated and medicated BD 
patients differed, both groups performed significantly worse than controls. Indeed, even within 
smaller samples of unmedicated SMD or BD youths, labeling deficits were evident. 
Second, comorbidity was high in BD, although comparable to rates reported in other 
pediatric BD studies (Biederman et al., 1999). For example, 69% of BD patients had anxiety and 
59% had ADHD diagnoses. However, as noted above, given that subjects with ANX/MDD or 
ADHD/CD were unimpaired on face-emotion labeling, it is unlikely that the presence of these 
conditions in children with BD accounts for their deficits. Third, BDs were tested irrespective of 
current mood state. However, emotion labeling deficits were present in euthymic BDs, 
suggesting that face-emotion misidentification may be a trait-based deficit in BD.  
Fourth, group differences in demographic characteristics (e.g., age, IQ, sex, ethnicity) 
may bias our results, although our analyses covaried these variables. We did not find that 
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emotion labeling ability varied by sex, but subsequent studies should include more females and a 
broader range of ages and ethnicities, particularly in ADHD/CD, BD, and SMD samples.  
Finally, although the DANVA is a standardized emotion labeling paradigm, the number 
of test items is small (24 child and 24 adult faces), particularly when broken down by emotions 
(6 faces per emotion per face-age). Therefore, the power to detect emotion-specific differences is 
limited.  
This study has two key clinical implications. First, combining pathophysiologically- and 
clinically-based measures can help address nosological questions. The identification of 
behavioral deficits common to both the narrow-BD and broad-SMD phenotypes informs 
discussion about the nosological relationship between these two syndromes (Leibenluft et al., 
2003). Additionally, the face-emotion labeling deficits reported here may indicate dysfunctional 
neural circuitry. As such, documented behavioral/cognitive impairments can be targeted for 
study with fMRI to identify neural correlates of underlying behavioral deficits, elucidate 
pathophysiology, and inform nosology. Second, documenting behavioral deficits specific to 
certain psychiatric disorders can aid in identifying targets for intervention. For example, an 
intervention developed for children with PDD has used rewards to reinforce facial stimuli and 
increase motivation for social interactions (Dawson & Zanolli, 2003). Our results suggest that 
social skills training with a facial affect labeling component may be an important part of 
treatment for BD and SMD youths. 
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Table 1. Demographic characteristics
BD SMD ANX/MDD ADHD/CD Controls df F U² p
(n=42) (n=39) (n=44) (n=35) (n=92)
Age (Years; Mean±SD) 12.8±2.5 11.8±2.1 13.1±2.5 14.8±1.6 14.4±2.4 247 12.63 — 0.000
IQ (Mean±SD) 108.5±14.5 104.9±14.9 109.4±15.6 100.7±15.5 108.7±15.3 247 2.36 — 0.054
Male, n(%) 22(52.4) 28(71.8) 23(52.3) 25(71.4) 47(51.1) 252 — 8.53 0.074
White ethnicity, n(%) 41(97.6) 36(92.3) 30(68.2) 21(60.0) 68(73.9) 252 — 23.87 0.000
Note: BD=Bipolar disorder; SMD=Severe mood dysregulation; ANX/MDD=Anxiety and/or Major depressive disorders;
ADHD/CD=Attention-deficit/hyperactivity and/or Conduct disorder. Groupings based on current diagnoses.
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Table 2. Clinical characteristics 
 BD SMD ANX/MDD ADHD/CD 
(n=42) (n=39) (n=44) (n=35) 
 
Lifetime diagnoses, n(%)     
Bipolar I 33(78.6) — — — 
Bipolar II 9(21.4) — — — 
Anxiety disorder 29(69.0) 24(61.5) 40(90.9) — 
Social phobia 7(16.7) 6(15.4) 25(56.8) — 
Generalized anxiety 17(40.5) 15(38.5) 20(45.5) — 
Panic disorder 4(9.5) 0 0 — 
Separation anxiety 15(35.7) 14(35.9) 8(18.2) — 
Specific/simple phobia 12(28.6) 8(20.5) 10(22.7) — 
Major depressive disorders a — 9(23.1) 18(40.9) — 
Attention deficit/hyperactivity disorder 25(59.5) 31(79.5) 4(9.1) 28(80.0) 
Conduct disorder 0 1(2.6) 0 17(48.6) 
Oppositional defiant disorder 18(40.9) 34(82.9) 11(23.9) 1(2.8) 
Psychosis 8(19.0) 0 — — 
 
Current medications, n(%)b
None 9(21.4) 22(56.4) 44(100.0) 18(51.4) 
Atypical antipsychotic 26(61.9) 9(23.1) — 1(2.9) 
Lithium 14(33.3) 8(20.5) — 0 
Antiepileptic 27(64.3) 8(20.5) — 0 
Stimulant 10(21.4) 8(20.5) — 16(45.7) 
Non-stimulant for ADHD 1(2.4) 2(5.1) — 4(11.4) 
Antidepressant 15(35.7) 3(7.7) — 8(22.9) 
Note: Comorbid diagnosis categories are not mutually exclusive within groups. aThirty-one BD 
had a history of a major depressive episode in addition to a euphoric manic episode. bExcept for 
ANX/MDD, most patients were taking multiple medications at testing. 
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Figure Caption  
Figure 1. Facial expression labeling errors. 
Notes: BD=Bipolar disorder; SMD=Severe mood dysregulation; ANX/MDD=Anxiety and/or 
Major depressive disorders; ADHD/CD=Attention-deficit/hyperactivity and/or Conduct disorder. 
Group effect: BD > ADHD/CD, ANX/MDD, and Controls, p<0.001; SMD > ANX/MDD, 
p<0.05; Emotion effect: Angry > Fearful, Sad, and Happy; Fearful > Sad and Happy; Sad > 
Happy; all p’s ]0.001. Means adjusted for age, sex, ethnic group, and IQ. 
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